含有帕克利塔塞尔的疗法在复发性/耐火性威尔姆斯瘤中的抗瘤活性
Alissa Groisser1, Amy Frantz1, James I Geller2
1Center For Cancer and Blood Disorders, Children's National Hospital and the Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA.
Pediatric blood & cancer
|July 27, 2025
概括
含有帕克利塔塞尔的疗法在复发的威尔姆斯瘤 (WT) 救援疗法中表现出活性. 这些治疗方法为耐火性WT患者提供了希望,需要进一步研究.
科学领域:
- 儿科瘤学 儿科瘤学
- 癌症治疗方法 癌症治疗方法
- 威尔姆斯瘤研究研究
背景情况:
- 之前的第二阶段研究表明单剂帕克利塔塞尔在复发的威尔姆斯瘤 (WT) 中具有活性.
- 基于帕克利塔塞尔的疗法被用作治疗耐药性WT的救援疗法.
- 这项研究旨在进一步描述含有帕克利塔塞尔的治疗方案在复发性WT中的临床活性.
研究的目的:
- 为了评估含有帕克利塔塞尔的疗法在患有复发威尔姆斯瘤的患者中的疗效.
- 评估严重预治疗WT患者的应答率和无进展生存时间.
主要方法:
- 多机构回顾性研究分析了来自28名复发性WT患者的匿名数据.
- 患者接受了帕克利塔塞尔或纳布-帕克利塔塞尔,通常与其他药物 (例如,多克索鲁比辛,凝丁) 结合使用.
- 在一次或两次循环后,使用固体瘤响应评估标准 (RECIST) 评估反应.
主要成果:
- 在26名有可测量疾病的患者中,有11名实现了部分反应 (PR).
- 两个没有可测量的疾病的患者保持了完全反应 (CR).
- 在这个重度预治疗的队列中,没有进展的平均持续时间为7.6个月 (范围:1-35个月).
结论:
- 含有帕克利塔塞尔的疗法在复发性WT中表现出活性,包括具有扩散性阿纳普拉西亚 (DA) 组织学的病例.
- 这些发现支持使用基于帕克利塔塞尔的疗法作为耐火性WT的救援选择.
- 建议进行前性研究,以正式证实基于帕克利塔塞尔的治疗疗法的疗效.
相关概念视频
01:15Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
01:27Tumor Immunotherapy
662
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
662
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K